Cargando…
Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening
Osteoporosis represents a major health problem, resulting in substantial increases in health care costs. There is an unmet need for a cost-effective technique that can measure bone properties without the use of ionizing radiation. The present study reports design, construction, and testing of a safe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044313/ https://www.ncbi.nlm.nih.gov/pubmed/32103042 http://dx.doi.org/10.1038/s41598-020-60173-5 |
_version_ | 1783501543719305216 |
---|---|
author | Makarov, Sergey N. Noetscher, Gregory M. Arum, Seth Rabiner, Robert Nazarian, Ara |
author_facet | Makarov, Sergey N. Noetscher, Gregory M. Arum, Seth Rabiner, Robert Nazarian, Ara |
author_sort | Makarov, Sergey N. |
collection | PubMed |
description | Osteoporosis represents a major health problem, resulting in substantial increases in health care costs. There is an unmet need for a cost-effective technique that can measure bone properties without the use of ionizing radiation. The present study reports design, construction, and testing of a safe, and easy to use radiofrequency device to detect osteoporotic bone conditions. The device uses novel on-body antennas contacting the human wrist under an applied, operator-controlled pressure. For the dichotomous diagnostic test, we selected 60 study participants (23–94 years old, 48 female, 12 male) who could be positively differentiated between healthy and osteopenic/osteoporotic states. The band-limited integral of the transmission coefficient averaged for both wrists, multiplied by age, and divided by BMI has been used as an index. For a 100 MHz frequency band centered about 890–920 MHz, the maximum Youden’s J index is 81.5%. Both the sensitivity and specificity simultaneously reach 87% given the calibration device threshold tolerance of ±3%. Our approach correlates well with the available DXA measurements and has the potential for screening patients at risk for fragility fractures, given the ease of implementation and low costs associated with both the technique and the equipment. The inclusion of radiofrequency transmission data does add supplementary useful information to the available clinical risk factors. |
format | Online Article Text |
id | pubmed-7044313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70443132020-03-04 Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening Makarov, Sergey N. Noetscher, Gregory M. Arum, Seth Rabiner, Robert Nazarian, Ara Sci Rep Article Osteoporosis represents a major health problem, resulting in substantial increases in health care costs. There is an unmet need for a cost-effective technique that can measure bone properties without the use of ionizing radiation. The present study reports design, construction, and testing of a safe, and easy to use radiofrequency device to detect osteoporotic bone conditions. The device uses novel on-body antennas contacting the human wrist under an applied, operator-controlled pressure. For the dichotomous diagnostic test, we selected 60 study participants (23–94 years old, 48 female, 12 male) who could be positively differentiated between healthy and osteopenic/osteoporotic states. The band-limited integral of the transmission coefficient averaged for both wrists, multiplied by age, and divided by BMI has been used as an index. For a 100 MHz frequency band centered about 890–920 MHz, the maximum Youden’s J index is 81.5%. Both the sensitivity and specificity simultaneously reach 87% given the calibration device threshold tolerance of ±3%. Our approach correlates well with the available DXA measurements and has the potential for screening patients at risk for fragility fractures, given the ease of implementation and low costs associated with both the technique and the equipment. The inclusion of radiofrequency transmission data does add supplementary useful information to the available clinical risk factors. Nature Publishing Group UK 2020-02-26 /pmc/articles/PMC7044313/ /pubmed/32103042 http://dx.doi.org/10.1038/s41598-020-60173-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Makarov, Sergey N. Noetscher, Gregory M. Arum, Seth Rabiner, Robert Nazarian, Ara Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening |
title | Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening |
title_full | Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening |
title_fullStr | Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening |
title_full_unstemmed | Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening |
title_short | Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening |
title_sort | concept of a radiofrequency device for osteopenia/osteoporosis screening |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044313/ https://www.ncbi.nlm.nih.gov/pubmed/32103042 http://dx.doi.org/10.1038/s41598-020-60173-5 |
work_keys_str_mv | AT makarovsergeyn conceptofaradiofrequencydeviceforosteopeniaosteoporosisscreening AT noetschergregorym conceptofaradiofrequencydeviceforosteopeniaosteoporosisscreening AT arumseth conceptofaradiofrequencydeviceforosteopeniaosteoporosisscreening AT rabinerrobert conceptofaradiofrequencydeviceforosteopeniaosteoporosisscreening AT nazarianara conceptofaradiofrequencydeviceforosteopeniaosteoporosisscreening |